Genotech Corporation (XKON:066830)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,150.00
-40.00 (-3.36%)
At close: May 11, 2026
Market Cap6.44B -17.6%
Revenue (ttm)7.28B +11.4%
Net Income-1.32B
EPS-280.00
Shares Out5.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,969
Average Volume1,488
Open1,150.00
Previous Close1,190.00
Day's Range1,012.00 - 1,150.00
52-Week Range805.00 - 1,600.00
Beta-0.09
RSI46.68
Earnings Daten/a

About Genotech

Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagn... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1997
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 066830
Full Company Profile